Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV000191134 | SCV000245543 | uncertain significance | Ehlers-Danlos syndrome due to tenascin-X deficiency | 2015-03-30 | criteria provided, single submitter | clinical testing | This variant has been found once in our laboratory in trans with another missense variant [R3211G] in a 40-year-old female with a clinical diagnosis of EDS type III, pain, hypermobility, fevers, night sweats, depression, GI problems, and hyperextensibility in her mother (who was negative for this change). This variant has been seen in our laboratory with other rare variants (phase undetermined) in a 2-year-old male [Q3848K] with tall habitus, joint pain and laxity, hyperelasticity, but also in 3 others without related related symptoms. |
Gene |
RCV001577104 | SCV001804430 | likely benign | not provided | 2021-05-28 | criteria provided, single submitter | clinical testing | |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002252042 | SCV002523354 | uncertain significance | See cases | 2019-04-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002277447 | SCV002565204 | benign | Ehlers-Danlos syndrome | 2021-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002372161 | SCV002690705 | benign | Cardiovascular phenotype | 2020-03-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001577104 | SCV004156232 | benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | TNXB: BP4, BS1, BS2 |